X

Xenon Pharmaceuticals Inc
NASDAQ:XENE

Watchlist Manager
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Watchlist
Price: 39.8 USD -1.34% Market Closed
Updated: May 19, 2024

Xenon Pharmaceuticals Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xenon Pharmaceuticals Inc
Research & Development Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Research & Development
-$167.5m
CAGR 3-Years
-49%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Research & Development
-$143.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Research & Development
-$131.8m
CAGR 3-Years
-50%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Research & Development
-$70.1m
CAGR 3-Years
-60%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Research & Development
-$42m
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
-32%
Spectral Medical Inc
TSX:EDT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Xenon Pharmaceuticals Inc's Research & Development?
Research & Development
-167.5m USD

Based on the financial report for Dec 31, 2023, Xenon Pharmaceuticals Inc's Research & Development amounts to -167.5m USD.

What is Xenon Pharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-48%

Over the last year, the Research & Development growth was -58%. The average annual Research & Development growth rates for Xenon Pharmaceuticals Inc have been -49% over the past three years , -48% over the past five years .